Case of capecitabine‑induced dermatomyositis (Record no. 8621)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | a |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20190514115934.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 190324b xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | AIKTC-KRRC |
| Transcribing agency | AIKTC-KRRC |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 8218 |
| Author | Saraswat, Neerja |
| 245 ## - TITLE STATEMENT | |
| Title | Case of capecitabine‑induced dermatomyositis |
| 250 ## - EDITION STATEMENT | |
| Volume, Issue number | Vol. 50(6), November-December |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Mumbai |
| Name of publisher, distributor, etc. | Wolter Kluwer |
| Year | 2018 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Pagination | 350-353p. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Dermatomyositis (DM) is an idiopathic, inflammatory connective tissue disorder characterized by symmetrical proximal myopathy and characteristic skin involvement. The pathogenesis of DM is widely debated; however, it is postulated to be an end result of immune‑mediated cascade, triggered by multiple environmental factors in a genetically predisposed individual. In addition to underlying malignancies, many drugs have been reported to be associated with DM. Capecitabine is a chemotherapeutic agent, approved by the United States‑Food and Drug Administration for the management of colonic, metastatic colonic, and metastatic breast carcinoma. It is converted into 5‑fluorouracil after oral intake. Common dose‑limiting toxicities associated with the usage of the capecitabine include increased bilirubin levels, diarrhea, and hand‑foot syndrome. DM‑induced by capecitabine has rarely been reported. Herein, we describe a patient of metastatic carcinoma breast, who developed DM after capecitabine intake. The patient had accidental re‑challenge with capecitabine resulting in the reappearance of the cutaneous and musculoskeletal system, thereby confirming our diagnosis of drug‑induced DM in the setting of underlying malignancy. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| 9 (RLIN) | 4774 |
| Topical term or geographic name entry element | PHARMACOLOGY |
| 653 ## - Keywords | |
| Keywords | Breast carcinoma |
| 653 ## - Keywords | |
| Keywords | Capecitabine |
| 653 ## - Keywords | |
| Keywords | Dermatomyositis |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 8219 |
| Co-Author | Verma, Rajesh |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 8220 |
| Co-Author | Shekha, Neema |
| 773 0# - HOST ITEM ENTRY | |
| Place, publisher, and date of publication | Andheri - Mumbai Wolters Kluwer India Private Limited |
| International Standard Serial Number | 0253-7613 |
| Title | Indian Journal of Pharmacology |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| URL | http://www.ijp-online.com/temp/IndianJPharmacol506350-1488709_040807.pdf |
| Link text | Click here |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Dewey Decimal Classification |
| Koha item type | Articles Abstract Database |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Shelving location | Date acquired | Total Checkouts | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dewey Decimal Classification | School of Pharmacy | School of Pharmacy | Archieval Section | 29/03/2019 | 2018289 | 19/06/2019 | 29/03/2019 | Articles Abstract Database |